AdaptHealth (AHCO) Stock Price, News & Analysis

Company Overview

AdaptHealth Corp. (NASDAQ: AHCO) is a provider of home medical equipment, medical supplies and related healthcare services in the United States. The company supports patients who require ongoing care outside of traditional healthcare facilities and works with physicians, hospitals, insurers and other referral sources to coordinate equipment delivery, setup and clinical support.

AdaptHealth’s offerings include respiratory equipment such as oxygen systems, ventilators and continuous positive airway pressure (CPAP) devices; diabetes supplies; sleep therapy products; mobility equipment; wheelchairs; wound-care products; and other home medical equipment and disposable supplies. It also provides services related to equipment education, resupply, monitoring and maintenance.

The company serves patients across the United States through a network of locations and distribution operations. AdaptHealth was established in 2012 and has expanded its presence through organic growth and acquisitions of home medical equipment providers. Its business primarily serves beneficiaries of Medicare and Medicaid, as well as patients covered by commercial health plans. Suzanne Foster serves as AdaptHealth’s chief executive officer.

Key Stats

• Today's Range: $5.56 to $5.76
• 50-Day Range: $5.22 to $11.22
• 52-Week Range: $5.21 to $13.43
• Volume: 2.10 million shs
• Average Volume: 2.76 million shs
• Market Capitalization: $759.41 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $10.14
• Consensus Rating: Moderate Buy

AdaptHealth Stock Analysis - MarketRank™

AdaptHealth scored higher than 84% of companies evaluated by MarketBeat, and ranked 71st out of 908 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

AdaptHealth has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on no strong buy ratings, 7 buy ratings, 1 hold rating, and 1 sell rating.

Upside Potential

AdaptHealth has a consensus price target of $10.14, representing about 82.1% upside from its current price of $5.57.

Amount of Analyst Coverage

AdaptHealth has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of AdaptHealth is -3.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of AdaptHealth is -3.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

AdaptHealth has a P/B Ratio of 0.49. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

7.21% of the float of AdaptHealth has been sold short.

Short Interest Ratio / Days to Cover

AdaptHealth has a short interest ratio ("days to cover") of 3.15, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in AdaptHealth has recently decreased by 7.31%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

AdaptHealth does not currently pay a dividend.

Dividend Growth

AdaptHealth does not have a long track record of dividend growth.

News and Social Media

• Score: 2.1 / 5
• News Sentiment: 0.34

News Sentiment

AdaptHealth has a news sentiment score of 0.34. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.74 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for AdaptHealth this week, compared to 4 articles on an average week.

Search Interest

Only 4 people have searched for AHCO on MarketBeat in the last 30 days. This is a decrease of -60% compared to the previous 30 days.

MarketBeat Follows

3 people have added AdaptHealth to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 3.6 / 5
• Insider Trading: Acquiring Shares

Net Insider Buying

Over the last three months, insiders have purchased a net $149,930.00 in company stock, which represents 0.0197% of the company's market cap.

Insider Buying vs. Insider Selling

In the past three months, AdaptHealth insiders have bought more of their company's stock than they have sold. Specifically, they have bought $149,930.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

1.95% of the stock of AdaptHealth is held by insiders.

Percentage Held by Institutions

82.67% of the stock of AdaptHealth is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/04/2026
• Today: 9/25/2026
• Next Earnings (Estimated): 11/03/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Distributors
• Current Symbol: NASDAQ:AHCO
• CIK: 1725255
• Web: www.adapthealth.com
• Phone: (610) 424-4515
• Fax: N/A
• Employees: 10,900
• Year Founded: 2012

Price Target and Rating

• Average Price Target for AdaptHealth: $10.14
• High Price Target: $13.00
• Low Price Target: $8.00
• Potential Upside/Downside: +82.1%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.67
• Research Coverage: 9 Analysts

Profitability

• EPS (Trailing Twelve Months): ($1.71)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$70.79 million
• Net Margins: -7.07%
• Pretax Margin: -7.24%
• Return on Equity: 3.36%
• Return on Assets: 1.16%

Debt

• Debt-to-Equity Ratio: 1.37
• Current Ratio: 1.12
• Quick Ratio: 0.98

Sales & Book Value

• Annual Sales: $3.24 billion
• Price / Sales: 0.23
• Cash Flow: $4.04 per share
• Price / Cash Flow: 1.38
• Book Value: $11.27 per share
• Price / Book: 0.49

Miscellaneous

• Outstanding Shares: 136,340,000
• Free Float: 133,685,000
• Market Cap: $759.41 million
• Optionable: Optionable
• Beta: 1.39